Trump’s 100% generic drug duty threatens US low-cost supply
- Posted on July 22, 2026
- By Business News Today
- 0 Views
- 1 min read
In brief
Generating AI summary…
Trump’s 100% generic drug duty threatens US low-cost supply
President Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028, rising to 200% a year later. The move threatens India's pharmaceutical exports, could disrupt low-cost medicine supplies, raise drug prices, and trigger shortages for millions of American patients.
